# Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer

> **NCT03103321** · PHASE3 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 158 (actual)

## Conditions studied

- Stage II Prostate Cancer
- Stage IIA Prostate Cancer
- Stage IIB Prostate Cancer
- Stage III Prostate Cancer
- Stage I Prostate Cancer
- PSA Level Five to Ten
- PSA Level Less Than Five
- PSA Level Ten to Fifty

## Interventions

- **OTHER:** Internet-Based Intervention
- **OTHER:** Internet-Based Intervention
- **OTHER:** Best Practice
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **OTHER:** Survey Administration
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT03103321
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-02
- **Primary completion:** 2019-12-05
- **Final completion:** 2020-11-25
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2025-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03103321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03103321, "Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03103321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*